2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Sunday, December 13, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Technology and Procedures, Assays, Omics Technologies, Bioinformatics, Gene Editing, Treatment Considerations, Biological Therapies, Antibody Therapy, Transplantation, Immunotherapy, Biological Processes, Pathogenesis, CHIP, Genomics, Hematopoiesis, Immune Mechanism, Metabolism, Molecular Biology, Diseases, Bleeding and Clotting, Platelet Disorders, Thrombocytopenias, Thrombotic Disorders, Genetic Disorders, Immunology, Research, Fundamental Science, Translational Research, Study Population, Human, Adult, Animal Model
PAPER

2997 Activation of focal adhesion kinase (FAK) and protein tyrosine kinase 2-beta (PYK2) by reactive oxygen species in platelets and their roles in mediating integrin outside-in signaling

Andrew G Mack, Can G Wang2, Yaping G Zhang3, Miles Eckrich4, David Schlaepfer, PhD5, Xiaoping Du, MD, PhD6
1 University of Illinois at Chicago, Chicago, Illinois, United States
2 University of Illinois at Chicago, Chicago, Illinois, United States
3 University of Illinois at Chicago, Chicago, Illinois, United States
4 University of Illinois at Chicago, Chicago, Illinois, United States
5 University of California San Diego, La Jolla, California, United States
6 University of Illinois at Chicago, Chicago, Illinois, United States

Ligand binding to platelet integrin αIIbβ3 mediates stable platelet adhesion and induces integrin outside-in signaling to facilitate platelet spreading, granule secretion, and the secondary wave of platelet aggregation, which greatly expands the platelet thrombi, a crucial component of pathological thrombosis. However, the outside-in signaling pathway leading to these responses are not well understood. Our previous studies have highlighted the importance of reactive oxygen species (ROS), particularly ROS generated by the nicotinamide adenine dinucleotide phosphate oxidase 2 (NOX2), in platelet activation and integrin outside-in signaling induced ROS generation (ATVB 2016, ATVB 2021). These studies further demonstrate that ROS-generated during outside-in signaling facilitated the activation of the tyrosine kinase Syk, a key enzyme in the GPVI associated ITAM signaling pathway. However, it remains unclear how ROS activates the Syk-dependent ITAM pathway.

 

Focal Adhesion Kinase (FAK) and its homolog Protein Tyrosine Kinase 2-beta (PYK2) are recognized in many cells to mediate integrin signaling following ligand binding. However, activation mechanisms of these two tyrosine kinases and how they transduce signaling pathways are largely unknown. Additionally, the role of these kinases in platelets is debated. Studies show PYK2-/- mouse platelets have aggregation defects, bleeding tendencies, and reduced thrombus formation, yet FAKfl/fl PF4 Cre+ mouse platelets have no aggregation defect and no impact on thrombosis, yet bleed longer, a confusing dichotomy we sought to resolve.

 

Here, we show integrin-dependent ROS generation downstream of Gα13-integrin binding and the Src-NOX2 signaling pathway is important in stimulating phosphorylation and activation of both FAK and PYK2, and ROS-dependent FAK and PYK2 activation facilitates the integrin outside-in signaling-mediated activation of Syk and the ITAM signaling pathway. FAKfl/fl PF4 Cre+ platelets exhibit defective spreading and adhesion to fibrinogen under shear. However, FAK knockout has minimal impacts on platelet aggregation. In contrast, PYK2-/- platelets showed defective platelet spreading as well as reduced secondary platelet aggregation. To investigate these mechanistic differences, we found that FAK phosphorylation and activation is reduced in PYK2 knockout platelets, whereas PYK2 activation is enhanced in FAK knockout platelets, suggesting the importance of PYK2 in FAK activation and a role for FAK in modulating PYK2 function. This finding also suggests a role of PYK2 in compensating the effect of FAK knockout on platelet function. To further investigate these effects, we generated FAKfl/fl PF4 Cre+ Pyk2-/- double knockout mice. We found the regulatory and compensatory relationship between FAK and PYK2 to be consistent as FAK and PYK2 double knockout yielded similar platelet functional effect as PYK2 knockout alone during platelet aggregation and in vivo thrombosis and bleeding time assays, suggesting that PYK2 functions as the dominant focal adhesion kinase in platelet aggregation. Furthermore, previous studies reported that FAK and PYK2 are activated by the collagen receptor GPVI and play roles in ITAM activation. We show that GPVI-dependent activation of FAK and PYK2 is inhibited in b3-/- platelets, indicating that integrin outside-in signaling is an important contributor to GPVI-mediated activation of FAK and PYK2, likely serving as a positive feedback loop. Together, this study demonstrates  a mechanism mediating the role of ROS in integrin outside-in signaling and how these two focal adhesion kinases are activated during and mediate integrin outside-in signaling.

Andrew G Mack: No relevant conflicts of interest to declare.